Shalini Sharp

Chief Financial Officer, Agenus.

Companies

Septerna, Inc.Board member Oct 24, 2024 to now¹
BeOne Medicines Ltd.Board member Oct 2, 2024 to now²
Organon & Co.Board member May 17, 2021 to now³
Neurocrine BiosciencesBoard member Feb 4, 2020 to now⁴
Mirati Therapeutics, Inc.Board member Mar 30, 2021 to Jan 23, 2024⁵
Sutro BiopharmaBoard member Nov 13, 2018 to Jun 8, 2022⁶
Precision BioSciencesBoard member Mar 27, 2019 to May 12, 2021⁷
Nuvation Bio Inc.Board member Jun 30, 2020 to Feb 26, 2021⁸
Ultragenyx Pharmaceutical Inc.Officer Jan 30, 2014 to Oct 16, 2020⁹
Ultragenyx Pharmaceutical Inc.Chief financial officer Feb 3, 2014 to Aug 19, 2020¹⁰
AgenusBoard member Jun 18, 2012 to Jun 22, 2018¹¹
AgenusChief financial officer Oct 5, 2006 to Apr 30, 2012¹²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Neurocrine Biosciences NBIX4,088 shares¹³$561.5K at $137.36May 21, 2026
BeOne Medicines Ltd. ONC9 shares¹⁴$3.3K at $371.86Jun 15, 2026
Organon & Co. OGN2 shares¹⁵$27 at $13.74Jun 13, 2023
Mirati Therapeutics, Inc.0 shares¹⁶Jan 23, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 11, 2026Granted 18,980 shares of BeOne Medicines Ltd.¹⁴
May 21, 2026Exercised options 1,659 shares of Neurocrine Biosciences¹³
May 22, 2025Exercised options 1,435 shares of Neurocrine Biosciences¹⁷
May 21, 2025Granted 10,985 shares of BeOne Medicines Ltd.¹⁸
Sep 30, 2024Granted 8,151 shares of BeOne Medicines Ltd.¹⁹
May 17, 2024Sold 1,106 shares at $141.90 of Neurocrine Biosciences²⁰
May 17, 2024Exercised options 2,100 shares of Neurocrine Biosciences²⁰
Jan 23, 2024Returned to company 6,808 shares of Mirati Therapeutics, Inc.¹⁶
Jan 23, 2024Returned to company 5,252 shares of Mirati Therapeutics, Inc.¹⁶
Jan 23, 2024Returned to company 4,162 shares of Mirati Therapeutics, Inc.¹⁶
Dec 29, 2023Granted 6,808 shares at $58.75 of Mirati Therapeutics, Inc.²¹
Jan 20, 2023Granted 4,444 shares of Mirati Therapeutics, Inc.²²
Jan 14, 2022Granted 2,546 shares of Mirati Therapeutics, Inc.²³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSepterna, Inc., Board member
2
SEC EDGARBeOne Medicines Ltd., Board member
3
SEC EDGAROrganon & Co., Board member
4
SEC EDGARNeurocrine Biosciences, Board member
5
SEC EDGARMirati Therapeutics, Inc., Board member
6
SEC EDGARSutro Biopharma, Board member
7
SEC EDGARPrecision BioSciences, Board member
8
SEC EDGARNuvation Bio Inc., Board member
9
SEC EDGARUltragenyx Pharmaceutical Inc., Officer
10
SEC EDGARUltragenyx Pharmaceutical Inc., Chief financial officer
11
SEC EDGARAgenus, Board member
12
SEC EDGARAgenus, Chief financial officer
13
SEC EDGARNeurocrine Biosciences shares after the filing of May 21, 2026
14
SEC EDGARBeOne Medicines Ltd. shares after the filing of Jun 15, 2026
15
SEC EDGAROrganon & Co. shares after the filing of Jun 13, 2023
16
SEC EDGARMirati Therapeutics, Inc. shares after the filing of Jan 23, 2024
17
SEC EDGARForm 4 filed May 22, 2025
18
SEC EDGARForm 4 filed May 22, 2025
19
SEC EDGARForm 4 filed Oct 2, 2024
20
SEC EDGARForm 4 filed May 21, 2024
21
SEC EDGARForm 4 filed Jan 3, 2024
22
SEC EDGARForm 4 filed Jan 24, 2023
23
SEC EDGARForm 4 filed Jan 18, 2022